Sangui Biotech International, Inc. Share Price OTC Markets
Equities
SGBI
US80105B1017
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | +25.00% | -.--% | -48.28% |
Sales 2021 | 65.58K 5.47M | Sales 2022 | 69.19K 5.77M | Capitalization | 3.09M 258M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | 90.6 x |
Net Debt 2021 | 790K 65.9M | Net Debt 2022 | 795K 66.29M | EV / Sales 2022 | 56.1 x |
P/E ratio 2021 |
-25.6
x | P/E ratio 2022 |
-51.8
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 86.94% |
1 day | +25.00% | ||
6 months | -48.28% | ||
Current year | -48.28% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 07/05/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 07/05/07 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 18/08/18 |
1st Jan change | Capi. | |
---|---|---|
+24.97% | 46.71B | |
+48.83% | 41.8B | |
-1.19% | 41.52B | |
-3.42% | 29.55B | |
+10.45% | 25.78B | |
-21.17% | 19.26B | |
+1.22% | 12.14B | |
-3.18% | 12.08B | |
+27.34% | 11.98B |
- Stock Market
- Equities
- SBH Stock
- SGBI Stock